Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Proxy-reported outcomes in clinical trials for children with rare and/or complex medical conditions: a scoping review and workshop with caregivers and trialists
EF 2023-24
Résumé
The study aims to describe the use of proxy-reported outcomes in clinical trials for children with rare and/or complex medical conditions and to identify implications for future patient- and family-centered trial design. Proxy-reported outcomes are study outcomes measured directly by a patient's report without interpretation by others. However, there are challenges associated with using PROs as trial outcomes, including their measurement when patients cannot report for themselves. Regulators such as the US Food and Drug Administration and the European Medicines Agency discourage proxy reporting of outcomes that reflect how a patient feels, preferring the inclusion of only observable outcomes when a caregiver is reporting trial outcomes on behalf of a patient.
The study will be co-designed by patient partners and pediatric trialists in the INFORM RARE research network. A scoping review will be conducted following the methods of the Joanna Briggs Institute and incorporating co-design practices. The primary researcher will identify clinical trials involving children with rare and/or complex conditions using electronic databases developed with the help of a specialist librarian. Citations will be screened for eligibility in two phases by two independent researchers.
With the help of the research team, the primary researcher will host a virtual workshop with caregivers of children with rare and/or complex conditions and pediatric trialists. The findings from the study will be used to inform future clinical trials and improve the quality of care for children with rare and/or complex diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
505822
Name
Al-Baldawi Yousif
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Proxy-reported outcomes in clinical trials for children with rare and/or complex medical conditions: a scoping review and workshop with caregivers and trialists
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Caregiver Perspectives; Inclusive Trial Design; Patient-Centered Trial Methods; Patient-Reported Outcome (Pro); Pediatric Clinical Trials; Proxy-Reported Outcomes; Quality Of Care; Rare And Complex Medical Conditions; Research Design; Research Methods
Abstract
The study aims to describe the use of proxy-reported outcomes in clinical trials for children with rare and/or complex medical conditions and to identify implications for future patient- and family-centered trial design. Proxy-reported outcomes are study outcomes measured directly by a patient's report without interpretation by others. However, there are challenges associated with using PROs as trial outcomes, including their measurement when patients cannot report for themselves. Regulators such as the US Food and Drug Administration and the European Medicines Agency discourage proxy reporting of outcomes that reflect how a patient feels, preferring the inclusion of only observable outcomes when a caregiver is reporting trial outcomes on behalf of a patient.
The study will be co-designed by patient partners and pediatric trialists in the INFORM RARE research network. A scoping review will be conducted following the methods of the Joanna Briggs Institute and incorporating co-design practices. The primary researcher will identify clinical trials involving children with rare and/or complex conditions using electronic databases developed with the help of a specialist librarian. Citations will be screened for eligibility in two phases by two independent researchers.
With the help of the research team, the primary researcher will host a virtual workshop with caregivers of children with rare and/or complex conditions and pediatric trialists. The findings from the study will be used to inform future clinical trials and improve the quality of care for children with rare and/or complex diseases.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Al-Baldawi, Yousif
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~